SM Report.docx - SUN PHARMA SWOT ANALYSIS STRENGHTS Sun...

SUN PHARMA
SWOT ANALYSIS
STRENGHTS
Sun Pharma being a successful organization over the years. They had successfully taken over
lots of companies for increasing their product-line e.g. Ranbaxy in 2015. They have a strong
presence in India and US. In India they are the leading pharmaceutical company in India and
in US they are on 4 th number in generic medicines. They usually spent in 7-8% in R&D every
year for innovation, manufacturing and the continuously focus on research efficiency.[Sun].
They have expertise in relatively complex generic pharmaceuticals and have low cost of
skilled manpower and proven track record in design of high technology manufacturing
devices.
WEAKNESSES
Strict pricing regulations always affect the profitability. The United States Food and Drug
Administration issued observations letters to the Halol facility for serious problems with the
testing programmers. [ETm16] At present Indian pharma sector is relatively unorganized.
With entry of branded pharma retail chains the industry is expected to get more and more
organized in the future. At present, there are a few big players such as Surya Pharmaceutical
(Viva), Lifetime Healthcare’s (LifeKen), MedPlus who dominate the organised pharmacy
retailing.[Rit12] Even tough competition from other major pharma brands means limited
scope for market share.
OPPORTUNITIES
India, a potential preferred global outsourcing hub for pharma products due to low cost
skilled labour and they have an opportunity increase healthcare awareness in urban and rural
India. According to index mundi 2015, 32% is now urban and as day by day pollution is
increasing in metropolitan city. People are more now aware about their health as well for their
family. And even in rural area, people are taking care of sanitation and garbage. As people are
getting aware about health they are asking for more quality healthcare and this could be an
opportunity for Sun Pharma to penetrate into the market.